Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (691-700 of 903) with videos related to

Pageof 91
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|January 24, 2009
Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) studyStefan Ropele, Alexandra Seewann, Alida A Gouw, et al.
Journal of Alzheimer'S Disease : JAD|June 30, 2020
Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic CohortMarijn Muurling, Hanneke F M Rhodius-Meester, Juha Pärkkä, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic PatientsWillemijn J Jansen, Ron L H Handels, Pieter Jelle Visser, et al.
Journal of the International Neuropsychological Society : JINS|October 13, 2020
Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's DiseaseRoos J Jutten, Sietske A M Sikkes, Rebecca E Amariglio, et al.
BMC Neurology|December 15, 2022
Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk scoreJori Tomassen, Anouk den Braber, Sven J van der Lee, et al.
Nutrients|May 26, 2019
Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD ProjectAstrid S Doorduijn, Marjolein Visser, Ondine van de Rest, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Neurobiology of Aging|January 24, 2012
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCIStephanie Vos, Ineke van Rossum, Leah Burns, et al.
Neurology|April 22, 2014
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functionsRik Ossenkoppele, Wiesje M van der Flier, Sander C J Verfaillie, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Pageof 91

Showing results (691-700 of 903) with videos related to

Sort By:
Pageof 91
Journal of Magnetic Resonance Imaging : JMRI|January 24, 2009
Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) studyStefan Ropele, Alexandra Seewann, Alida A Gouw, et al.
Journal of Alzheimer'S Disease : JAD|June 30, 2020
Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic CohortMarijn Muurling, Hanneke F M Rhodius-Meester, Juha Pärkkä, et al.
Journal of Alzheimer'S Disease : JAD|October 8, 2016
The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic PatientsWillemijn J Jansen, Ron L H Handels, Pieter Jelle Visser, et al.
Journal of the International Neuropsychological Society : JINS|October 13, 2020
Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's DiseaseRoos J Jutten, Sietske A M Sikkes, Rebecca E Amariglio, et al.
BMC Neurology|December 15, 2022
Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk scoreJori Tomassen, Anouk den Braber, Sven J van der Lee, et al.
Nutrients|May 26, 2019
Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD ProjectAstrid S Doorduijn, Marjolein Visser, Ondine van de Rest, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Neurobiology of Aging|January 24, 2012
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCIStephanie Vos, Ineke van Rossum, Leah Burns, et al.
Neurology|April 22, 2014
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functionsRik Ossenkoppele, Wiesje M van der Flier, Sander C J Verfaillie, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Pageof 91